TNFRSF9 and neoplasm: 4-1BBL (TNFRSF9/CD137) costimulation of tumor-specific T cells is important for T-cell activation and 4-1BBL transfected DCs elicit more effective responses and enhanced CTL killing of tumor cells, due to increased expression of perforin and IFN-γ [35].